Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial

BACKGROUND: The phosphodiesterase inhibitor cilostazol has beneficial effects on atherosclerosis by virtue of vasodilatory and antiplatelet effects. However, less is known about the effect of cilostazol on arterial stiffness and biochemical markers related to vascular inflammation and endothelial dy...

詳細記述

保存先:
書誌詳細
主要な著者: Kim, Nam Hoon, Kim, Hee Young, An, Hyonggin, Seo, Ji A, Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Choi, Dong Seop, Kim, Sin Gon
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3733748/
https://ncbi.nlm.nih.gov/pubmed/23886346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-41
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料